Online Monitors (OMO)

42 market research is operating the Online Monitor (OMO) - a powerful patient tracker.

Unlike other "snap shot" monitors, the OMO is the continuous documentation of every patient being treated for the following indications:-

Breast Cancer	Head and Neck Tumours
Non-Small Cell Lung Cancer (NSCLC)	Rheumatoid Arthritis
Colorectal Cancer	Diabetes
Prostate Cancer	Haematological Diseases
Non-Hodgkin Lymphoma (NHL)	Nephrological Diseases
Renal Carcinoma	Cardiovascular Diseases
Ovarian Cancer	CNS Diseases
Brain Tumours	HIV

The OMO is developed, designed, programmed, hosted and operated exclusively by 42 market research.

For a more detailed overview on the OMO please click here.